Mypox (5381) Reports Latest Earnings: Operating Income Surges 343.4% YoY to 373 Million Yen, Revenue Up 20.5%

Mypox (5381) has released its financial results, reporting revenue of 3,247 million yen, representing a solid 20.5% increase year-on-year. Profitability showed significant improvement, with operating income surging 343.4% year-on-year to 373 million yen. Additionally, ordinary income reached 408 million yen, net income attributable to owners of the parent was 246 million yen, and earnings per share (EPS) stood at 17.71 yen.

From a financial and valuation perspective, the company maintains a robust liquidity position with 3.08 billion yen in cash and cash equivalents, supported by positive operating cash flow of 320 million yen (while free cash flow registered -210 million yen due to investments). Profitability metrics show a Return on Equity (ROE) of 6.09%, a Return on Assets (ROA) of 2.80%, and an EBITDA of approximately 1.35 billion yen. Overall, the results highlight a substantial expansion in earnings capacity backed by solid top-line growth.